Literature DB >> 3192734

Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes.

G Senaldi1, B A Millward, M J Hussain, D A Pyke, R D Leslie, D Vergani.   

Abstract

Low serum concentrations of the fourth component of complement (C4) are found in insulin dependent diabetes, and may be important in the aetiology of the disease. To ascertain whether function of C4 is also impaired both its haemolytic activity and its concentration were measured in 34 insulin dependent diabetics, 15 non-insulin dependent diabetics, 20 healthy subjects, and 12 pairs of monozygotic twins discordant for insulin dependent diabetes. C4 function was measured by a radial immune haemolytic assay, and C4 concentration by laser nephelometry. Both measurements were significantly lower in insulin dependent diabetics (C4 function: median 47%, range 4-100%; C4 concentration: 0.22 g/l, 0.10-0.38 g/l) than in non-insulin dependent diabetics (67%, 33-138%, p less than 0.01; 0.27 g/l, 0.16-0.50 g/l, p less than 0.02) and controls (74%, 33-138%, p less than 0.01; 0.27 g/l, 0.18-0.40 g/l, p less than 0.03). C4 function and concentration were lower in both diabetic (48%, 12-100%; 0.17 g/l, 0.08-0.31 g/l) and non-diabetic twins (47%, 12-100%; 0.17 g/l, 0.07-0.36 g/l) than controls (p less than 0.01; p less than 0.01). Thirteen (38%) of the insulin dependent diabetics had a reduction in either C4 function or concentration, but in only five were both features reduced. Values of function and concentration were strongly correlated in both diabetic and non-diabetic twins (r = 0.95, p less than 0.001; r = 0.92, p less than 0.001). These results show defects in C4 function and concentration in insulin dependent diabetes, which--being present in the non-diabetic co-twin of diabetics--may represent a genetic predisposition to the disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192734      PMCID: PMC1141698          DOI: 10.1136/jcp.41.10.1114

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Evidence for HL-A-linked genes in "juvenile" diabetes mellitus.

Authors:  A G Cudworth; J C Woodrow
Journal:  Br Med J       Date:  1975-07-19

2.  Complement in type 1 (insulin-dependent) diabetes.

Authors:  G Senaldi; B A Millward; M J Hussein; D Pyke; R D Leslie; D Vergani
Journal:  Diabetologia       Date:  1987-10       Impact factor: 10.122

3.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Neutralization of sensitized virus by the fourth component of complement.

Authors:  C A Daniels; T Borsos; H J Rapp; R Snyderman; A L Notkins
Journal:  Science       Date:  1969-08-01       Impact factor: 47.728

5.  Diabetes in identical twins. A study of 200 pairs.

Authors:  A H Barnett; C Eff; R D Leslie; D A Pyke
Journal:  Diabetologia       Date:  1981-02       Impact factor: 10.122

6.  Low plasma C4 concentrations: association with microangiopathy in insulin dependent diabetes.

Authors:  A H Barnett; C Mijovic; J Fletcher; I Chesner; B M Kulkuska-Langlands; R Holder; A R Bradwell
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-13

7.  HLA and complement allotypes in Type 1 (insulin-dependent) diabetes.

Authors:  J McCluskey; V J McCann; P H Kay; P J Zilko; F T Christiansen; G J O'Neill; R L Dawkins
Journal:  Diabetologia       Date:  1983-03       Impact factor: 10.122

8.  Complement and HLA. Further definition of high-risk haplotypes in insulin-dependent diabetes.

Authors:  S Rich; G O'Neill; A P Dalmasso; C Nerl; J Barbosa
Journal:  Diabetes       Date:  1985-05       Impact factor: 9.461

9.  Nonenzymatic glycosylation of protein: relevance to diabetes.

Authors:  H F Bunn
Journal:  Am J Med       Date:  1981-02       Impact factor: 4.965

10.  Inherited structural polymorphism of the fourth component of human complement.

Authors:  Z L Awdeh; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.